Study ID: IXR-102-22-188
Study Title
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Teva Identifier
- IXR-102-22-188
ClinicalTrials.gov Identifier
- NCT00071539
Study Status
- Completed
Trial Condition(s)
- Recurrent Glioblastoma Multiforme
Interventions
- Drug: TP-38 | Drug: TP38
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 10/01/2003 - 07/01/2006
Phase
- Phase 2
Study Type
Interventional
